44 Participants Needed

DBT + CBT for Insomnia for Adolescents at High Risk of Suicide

Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The proposed research addresses the urgent need to reduce suicide rates among teens. This will be the first study that the investigators know of that will examine the feasibility and preliminary effectiveness of augmenting a suicide-focused treatment (Dialectical Behavior Therapy, \[DBT\]) with an evidence-based treatment protocol for insomnia (a digital version of Cognitive Behavioral Therapy for Insomnia \[CBT-I\]). The goal of this clinical trial is to learn providing insomnia treatment in conjunction with suicide-focused treatment leads to greater reductions in suicidality and self-harm than suicide-focused treatment alone. Participants will be randomly assigned to receive 6 months of DBT plus CBT-I or to DBT alone and will complete research assessments measuring suicidal ideation, self-harm behavior and insomnia symptoms every four weeks over the course of the study, as well as one post-treatment follow-up assessment. Participants will also wear a device on their wrist (like a Fitbit or wristwatch) for 10 days following each assessment to collect data about their sleep.

Do I have to stop taking my current medications for the trial?

The trial requires that if you are taking medication for psychiatric disorders or sleep, you must be on a stable dose for more than 2 months. This means you can continue your current medications as long as they have been stable for that period.

What data supports the effectiveness of the treatment DBT + CBT for Insomnia for Adolescents at High Risk of Suicide?

Research shows that addressing sleep disturbances, like insomnia, can reduce suicidal thoughts and behaviors in adolescents. Dialectical Behavior Therapy (DBT) has been effective in decreasing suicide attempts and related risk factors in high-risk adolescents, while Cognitive Behavioral Therapy for Insomnia (CBT-I) has been shown to reduce suicidal ideation in other populations, such as veterans.12345

Is DBT + CBT for Insomnia safe for adolescents at high risk of suicide?

Cognitive Behavioral Therapy for Insomnia (CBT-I) has been shown to be safe and can reduce suicidal thoughts in people with insomnia, including those with depression. Dialectical Behavior Therapy (DBT) is also generally considered safe and is used to help manage emotions and reduce self-harm behaviors.13567

How is Dialectical Behavior Therapy (DBT) unique for treating insomnia in adolescents at high risk of suicide?

Dialectical Behavior Therapy (DBT) is unique because it combines strategies for acceptance and change, helping adolescents manage emotions and reduce suicidal behaviors, which is particularly beneficial for those with high suicide risk. Unlike other treatments, DBT also involves family therapy components, addressing both individual and family dynamics to support the adolescent's overall well-being.4891011

Eligibility Criteria

This trial is for English-speaking teens aged 12-18 who are at high risk for suicide, have had a suicide attempt or multiple self-harm episodes, and suffer from insomnia. They must be on stable medication if they're taking any for psychiatric disorders or sleep issues, and live at home with a family member willing to participate.

Inclusion Criteria

High suicide risk, defined as: >1 lifetime suicide attempt, > 3 lifetime SH episodes (with at least 1 in the 12 weeks before baseline screening) and elevated SI (โ‰ฅ31 on the SIQ-Jr.)
My psychiatric or sleep medication dose has been stable for over 2 months.
Youth and parent both speak English
See 4 more

Exclusion Criteria

Significant current mania or psychosis; life-threatening anorexia, or other diagnosis of a severe mental or physical condition requiring treatment specific to that disorder and/or that interferes with participation in assessments or treatment
A history of being diagnosed with an Autism Spectrum Disorder
My insomnia is significantly affected by substance use or stopping certain medications.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 6 months of Dialectical Behavior Therapy (DBT) with or without Cognitive Behavioral Therapy for Insomnia (CBT-I)

24 weeks
Research assessments every 4 weeks

Follow-up

Participants complete a post-treatment follow-up assessment and wear a device to collect sleep data

4 weeks
1 post-treatment follow-up assessment

Treatment Details

Interventions

  • Cognitive Behavioral Therapy for Insomnia
  • Dialectical Behavior Therapy
Trial OverviewThe study tests whether adding digital Cognitive Behavioral Therapy for Insomnia (CBT-I) to Dialectical Behavior Therapy (DBT) helps reduce suicidal thoughts and behaviors more effectively than DBT alone in adolescents. Participants will also wear a sleep-tracking device.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Dialectical Behavior Therapy + Cognitive Behavioral Therapy for InsomniaExperimental Treatment2 Interventions
Group II: Dialectical Behavior Therapy OnlyActive Control1 Intervention

Dialectical Behavior Therapy is already approved in United States, European Union for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as DBT for:
  • Borderline Personality Disorder
  • Suicidal Behavior
  • Emotional Dysregulation
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as DBT for:
  • Borderline Personality Disorder
  • Suicidal Behavior
  • Emotional Dysregulation

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

In a study of 206 adolescents aged 12-17 in a suicide prevention program, initial insomnia symptoms were linked to a higher risk of suicide attempts within six months after discharge, highlighting the importance of addressing sleep issues in at-risk youth.
While insomnia symptoms at discharge did not directly predict attempts, persistent suicidal thoughts at discharge were strongly associated with future attempts, suggesting that treating both insomnia and suicidal ideation could be crucial in reducing suicide risk.
The association between baseline insomnia symptoms and future suicide attempts within an intensive outpatient treatment program for suicide.Lau, JW., Stewart, SM., King, JD., et al.[2022]
Adolescent suicide completers exhibited significantly higher rates of sleep disturbances, including insomnia and hypersomnia, compared to a matched control group, indicating a strong link between sleep issues and suicide risk.
The study suggests that sleep difficulties are prevalent in the week leading up to suicide and should be a focus in prevention and intervention strategies for at-risk adolescents, as they may serve as important warning signs.
Sleep disturbance preceding completed suicide in adolescents.Goldstein, TR., Bridge, JA., Brent, DA.[2022]
In a study of 691 adolescents in an intensive outpatient program, sleep disturbance was consistently linked to suicidal ideation (SI), with higher sleep issues at admission predicting greater SI at discharge.
The results indicated that addressing sleep disturbances during treatment could potentially reduce the risk of suicidal thoughts and behaviors, as those with severe SI showed increased sleep problems, while those without SI reported significant improvement in sleep.
Persistent suicidal ideation in a large intensive outpatient adolescent population sample: A preliminary report on the role of sleep disturbance.Gazor, A., Brown, WD., Naqvi, SK., et al.[2022]

References

The association between baseline insomnia symptoms and future suicide attempts within an intensive outpatient treatment program for suicide. [2022]
Sleep disturbance preceding completed suicide in adolescents. [2022]
Persistent suicidal ideation in a large intensive outpatient adolescent population sample: A preliminary report on the role of sleep disturbance. [2022]
Implementation of Dialectical Behavior Therapy with Suicidal and Self-Harming Adolescents in a Community Clinic. [2022]
Effects of cognitive behavioral therapy for insomnia on suicidal ideation in veterans. [2022]
When Night Falls Fast: Sleep and Suicidal Behavior Among Adolescents and Young Adults. [2022]
Initial Low Levels of Suicidal Ideation Still Improve After Cognitive Behavioral Therapy for Insomnia in Regular Psychiatric Care. [2021]
[Dialectical Behaviour Therapy for adolescents (DBT-A)--a pilot study on the therapy of suicidal, parasuicidal, and self-injurious behaviour in female patients with a borderline disorder]. [2022]
Family therapy and dialectical behavior therapy with adolescents: Part I: Proposing a clinical synthesis. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Dialectical behavior therapy for suicidal adolescents with borderline personality disorder. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Effectiveness of the family-based model of dialectical behavior therapy for both suicidal adolescents and young adults in an academic medical center. [2022]